Arixtra Injection, Solution
Product Images NDC 67457-593

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Arixtra (NDC 67457-593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 And 2 (Image 01)

FDA Label Image

Figure 3 And 4 (Image 02)

FDA Label Image

Fondaparinux Sodium Structural Formula (Image 03)

FDA Label Image

Arixtra-syringe-1 (Image 04)

FDA Label Image

Arixtra-syringe-2 (Image 05)

FDA Label Image

Arixtra-syringe-3 (Image 06)

FDA Label Image

Arixtra-figure-a (Image 07)

FDA Label Image

Arixtra-figure-b (Image 08)

FDA Label Image

Arixtra-figure-c (Image 09)

FDA Label Image

Arixtra-figure-d (Image 10)

FDA Label Image

Arixtra-figure-e (Image 11)

FDA Label Image

Arixtra-figure-f (Image 12)

FDA Label Image

Arixtra Injection 2.5 mg/0.5 mL Carton Label (Image 13)

This is a product description of a medication called fondaparinux sodium injection, USP, used for subcutaneous injection. This medication contains 10 single-dose prefilled syringes with an automatic needle protection system. The text also includes a warning for the pharmacist to dispense the accompanying patient information leaflet to each patient. The rest of the text appears to contain code numbers and irrelevant characters.*

FDA Label Image

Arixtra Injection 5 mg/0.4 mL Carton Label (Image 14)

FDA Label Image

Arixtra Injection 7.5 mg/0.6 mL Carton Label (Image 15)

This is a description of a medication named "Fondaparinux Sodium Injection, USP", indicated for subcutaneous injection and being sold in a package containing 10 prefilled syringes with an automatic needle protection system. The package's lot number and expiration date can be found on it. There is also a recommendation for storing the medication at room temperature (20°C to 25°C) and for dispensing a patient information leaflet to each patient. The rest of the text is not legible.*

FDA Label Image

Arixtra Injection 10 mg/0.8 mL Carton Label (Image 16)

This text appears to be a label for a medication called Fondaparinux Sodium Injection, prescribed for subcutaneous injection. The label includes dosage information (0°C BEF to 8 893 USP Corfrolid Foom Temperstre), instructions for pharmacists (to dispense patient information leaflets), and details about the packaging (10 single-dose, prefilled syringes with an automatic needle protection system). It also includes the NDC code (67467-595-08) for the medication as well as manufacturer information (Mylan) and lot and expiration details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.